Skip to main content
VCbacked
Log inGet Started

Kate Therapeutics

San Diego, United States

Kate Therapeutics is a biotechnology company focused on developing next-generation gene therapies for muscle and heart diseases.

$21.8M raised
Aug 2024
Series B
BiotechnologyHealth CareTherapeutics

Top Investors

Versant VenturesOUP (Osage University Partners)Westlake Village BioPartnersUF Innovate Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kate Therapeutics

How much funding has Kate Therapeutics raised?
Kate Therapeutics has raised $21.8M in total funding. The most recent round was Series B. The last funding was announced in August 2024.
Who are Kate Therapeutics's investors?
Kate Therapeutics's investors include Versant Ventures, OUP (Osage University Partners), Westlake Village BioPartners, UF Innovate Ventures.
Where is Kate Therapeutics headquartered?
Kate Therapeutics is headquartered in San Diego, United States.
What does Kate Therapeutics do?
Kate Therapeutics is a biotechnology company focused on developing next-generation gene therapies for muscle and heart diseases.
What stage is Kate Therapeutics at?
Kate Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Kate Therapeutics — Funding & Investors." VCBacked, August 7, 2024, https://www.vcbacked.co/company/kate-therapeutics. Accessed June 10, 2026.
APA
VCBacked. (2024). Kate Therapeutics — Funding & Investors. Retrieved June 10, 2026, from https://www.vcbacked.co/company/kate-therapeutics
Wikipedia (cite web)
{{cite web |title=Kate Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kate-therapeutics |website=VCBacked |access-date=June 10, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong